Disparities in the management of cardiogenic shock complicating acute myocardial infarction: a questionnaire survey in Beijing

• by Yidan Ren, Yuwei Liu, Yaxin Xie, Chenxu Zhao, Xiaqiu Tian, Liangshan Wang, Zhongtao Du, Xing Hao, Chenglong Li, Xiaotong Hou, Hong Wang

• September 25, 2026

AHA: Coffee Need Not Be Avoided in AF

Moderate coffee consumption generally appeared safe for most adults, but randomized evidence suggested divergent effects on atrial fibrillation and premature ventricular contractions.

• by Andrea Surnit

• July 20, 2026

• 5 min

Specific treatment of ATTR-CM in Germany—expert consensus of the German Society of Amyloid Diseases (DGAK) and German Cardiac Society (DGK)

• by Fabian aus dem Siepen, Teresa Trenkwalder, Birgit Aßmus, Ingrid Kindermann, Daniel Lavall, Sebastian Spethmann, Lars Michel, Timon Hansen, Sebastian Kruck, Christoph Rischpler, Fabian Knebel, Stéphanie K. Schwarting, Udo Bavendiek, Maria Papathanasiou, Ute Hegenbart, Ali Yilmaz, Katrin Hahn, Alexander Carpinteiro, Roman Pfister, Caroline Morbach

• September 22, 2026

Troponin Screening and Major Cardiovascular Adverse Events During Immune Checkpoint Inhibitor Therapy

• by Imen Hamdi, Nathan El Bèze, Soledad Henriquez, Marie-Liesse Joulia, Raphaël Colle, Delphine Loirat, Nicolas Girard, Agnès Lillo Le Louet, Christophe Caussin, Mariana Mirabel

• July 21, 2026